Studies have shown that RNCR3 can activate the Akt/GSK3β signaling pathway in gliomas to exert its cancer-promoting effect [13], so we verified the effect of RNCR3 on the Akt/GSK3β signaling pathway in HCC. This evidence concerns the gene GSK3B and hepatocellular carcinoma.